AMERICAN CENTURY COMPANIES INC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 748054 KANSAS CITY, MO

Position in RXRX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,492,860

+$539,828 QoQ

Shares Held

406,774

+31.0% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#63

of 344 holders

Holding Since

Sep 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AMERICAN CENTURY COMPANIES INC holds $3,618,743,392 across 179 Biotechnology names. RXRX ranks #81 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,853,956	$558,096,374
2	ASND	Ascendis Pharma A/S	1,400,575	$373,561,364
3	VRTX	Vertex Pharmaceuticals Inc / Ma	580,901	$288,550,953
4	ARGX	Argenx SE	173,193	$160,683,269
5	IONS	Ionis Pharmaceuticals Inc	1,947,076	$154,383,656
6	EXEL	Exelixis, Inc.	1,791,664	$97,484,438
7	HRMY	Harmony Biosciences Holdings, Inc.	2,539,512	$92,463,631
8	GPCR	Structure Therapeutics Inc.	1,682,179	$90,282,546

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,492,860	406,774	+31.0%	Shares	Defined	2026-08-12
2026-03-31	$953,032	310,434	+28.3%	Shares	Defined	2026-05-15
2025-12-31	$989,636	241,965	-23.5%	Shares	Defined	2026-02-13
2025-09-30	$1,542,948	316,178	+2463.5%	Shares	Defined	2025-11-12
2024-03-31	$122,969	12,334	-55.6%	Shares	Defined	2024-05-14
2023-12-31	$274,088	27,798	-67.6%	Shares	Defined	2024-02-13
2023-09-30	$657,326	85,925	+741.3%	Shares	Defined	2023-11-13
2023-06-30	$76,291	10,213	-96.6%	Shares	Defined	2023-08-14
2022-03-31	$2,162,205	301,984	-0.4%	Shares	Defined	2022-05-11
2021-12-31	$5,191,263	303,051	+100.2%	Shares	Defined	2022-02-07
2021-09-30	$3,482,770	151,359	—	Shares	Defined	2021-11-10
No filing history on record for this holder in this stock.